Confocal Microscopy Predicts the Risk of Recurrence and Malignant Transformation of Mucocutaneous Neurofibromas in NF-1: An Observational Study
暂无分享,去创建一个
[1] R. Sciot,et al. The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors , 2018, Neuro-oncology.
[2] B. Korf,et al. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study , 2018, Orphanet Journal of Rare Diseases.
[3] Á. Nagy,et al. [Pathogenic alterations within the neurofibromin gene in various cancers]. , 2017, Magyar Onkológia.
[4] D. Evans,et al. Increased risk of breast cancer in neurofibromatosis type 1: current insights , 2017, Breast cancer.
[5] D. Cooper,et al. The NF1 somatic mutational landscape in sporadic human cancers , 2017, Human Genomics.
[6] K. Busam,et al. The NF1 gene in tumor syndromes and melanoma , 2017, Laboratory Investigation.
[7] C. Romano,et al. Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform. , 2017, European journal of medical genetics.
[8] D. Gutmann,et al. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1. , 2017, Annual review of pathology.
[9] C. Liao,et al. The role of nerve microenvironment for neurofibroma development , 2016, Oncotarget.
[10] N. Ratner,et al. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor , 2015, Nature Reviews Cancer.
[11] M. Guida,et al. High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study , 2010, Journal of Translational Medicine.
[12] M. Mahalingam. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma , 2017, Advances in anatomic pathology.